Adimab Records Another Year of Double-Digit Clinical Program Growth
PR Newswire —
– 11 New Clinical Programs in 2025 – – 6 Partner Programs Have Reached the Market – – 89 Total Clinical Programs Initiated to Date – LEBANON, N.H., Jan. 13, 2026 /PRNewswire/ -- Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific...